1. Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX‐CAPTURE. (11th May 2017) Authors: Otero, M.E.; van den Reek, J.M.; Seyger, M.M.; van de Kerkhof, P.C.; Kievit, W.; de Jong, E.M. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX‐CAPTURE. (1st August 2017) Authors: Otero, M.E.; van den Reek, J.M.; Seyger, M.M.; van de Kerkhof, P.C.; Kievit, W.; de Jong, E.M. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and influence of body surface area on usage. (19th April 2017) Authors: Iversen, L.; Lange, M.M.; Bissonette, R.; Carvalho, A.V.E.; van de Kerkhof, P.C.; Kirby, B.; Kleyn, C.E.; Lynde, C.W.; van der Walt, J.M.; Wu, J.J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 7(2017) Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗